Continuity at the Head of the Management Board

Gerresheimer CEO Dr. Axel Herberg Hands Over Top Job to Uwe Röhrhoff in June

Gerresheimer Achieves Sales Target for 2009

Profit Margin Better Than Expected

DUSSELDORF, Germany, February 9 -

Gerresheimer Sets up New Production Facility for Insulin Pen Systems in Brazil

Expansion of Cooperation With Diabetes Leader Novo Nordisk

DÜSSELDORF, Germany, January 11 - The Gerresheimer Group has set up a new facility for medical
plastic systems in Indaiatuba (Brazil). The plant is to commence operations
early in 2010. On the basis of a long-term cooperation agreement with Novo
Nordisk, components will be produced with state-of-the-art technology for
insulin pen systems for diabetics.

Gerresheimer has Passed the Turning Point

DÜSSELDORF, Germany -

- Nine-Month Sales (Excluding Technical Plastics) 1.7% Down on Prior Year

Gerresheimer Expands in the Global Pharmaceutical Plastic Business

DÜSSELDORF, Germany -

- Important Investments for Pharmaceutical Markets in the USA and Europe

Gerresheimer Holds its own in Difficult Environment

DÜSSELDORF, Germany -

- Sales in the First Half of 2009 (Excluding Technical Plastics) at Prior Year Level

Gerresheimer Sells Technical Plastics Business

DUSSELDORF, Germany - Gerresheimer AG, a leading manu­facturer of glass and plastic products for the pharma & life science industry, has sold its Technical Plastics operations, which are not part of the MDAX company’s core business, to the FBH Group, Bad Soden, Germany. “Through the sale of the Technical Plastics segment Gerresheimer has - as formerly announced - taken a further step in its focus on the core business of pharma & life science,” says Dr. Axel Herberg, CEO of Gerresheimer AG.

Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China

DUSSELDORF, Germany - Now Seven Plants in China

The Gerresheimer Group today opened a new plant for pharmaceutical glass packaging in China. The high-tech production facility constructed in Danyang (Jiangsu Province) covers 16,000 square meters. Specializing in high-quality pharmaceutical vials and cartridges for injection systems it serves the pharma & life science industry on both a local and international level. Dr. Axel Herberg, CEO of Gerresheimer AG, describes the investment as a very important strategic step for further business expansion in Asia. In China, Gerresheimer now operates seven production plants for highly specific glass and plastic products.

Standard & Poor’s Confirms Rating for Gerresheimer

DUSSELDORF, Germany - The rating agency Standard & Poor’s has today confirmed the current rating of BB+ for the Gerresheimer Group and continues to categorize the outlook as stable. The focus of the MDAX company on the pharma & life science industry is therefore assessed as positive and sustainable by the rating agency.

Gerresheimer AG Expands its Management Board: Andreas Schutte Appointed as New Member

DUSSELDORF, Germany - Mr. Andreas Schutte (47) has been appointed to the Management Board of Gerresheimer AG with effect from May 1, 2009.

2008 a Record Year for Gerresheimer

DUSSELDORF, Germany - Strong Focus on the Markets of Pharma & Life Science

- Annual General Meeting Passes Dividend of EUR0.40 per Share

Gerresheimer Achieves Solid Growth in Core Markets - Outlook Confirmed

DUSSELDORF, Germany - Group Sales in the First Quarter of 2009 at Prior Year Level; Sales up Almost 3% in the Core Business Despite Difficult Market Environment

Latest Tweets

Gerresheimer AG

  • mathiastest Gerresheimer AG http://bit.ly/9GTjj3
Protected by Comment Guard Pro